Somewhat Positive Press Coverage Somewhat Unlikely to Impact CAS Medical Systems (CASM) Share Price

Share on StockTwits

Press coverage about CAS Medical Systems (NASDAQ:CASM) has been trending somewhat positive on Friday, according to Accern. Accern identifies negative and positive news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. CAS Medical Systems earned a media sentiment score of 0.08 on Accern’s scale. Accern also gave media headlines about the medical technology company an impact score of 45.4382233579164 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

Separately, ValuEngine raised CAS Medical Systems from a “hold” rating to a “buy” rating in a report on Thursday, May 17th.

CASM traded down $0.05 during trading on Friday, reaching $2.15. The company’s stock had a trading volume of 95,721 shares, compared to its average volume of 122,567. CAS Medical Systems has a 52-week low of $0.59 and a 52-week high of $2.70. The company has a current ratio of 3.23, a quick ratio of 2.84 and a debt-to-equity ratio of -0.66. The firm has a market capitalization of $64.70 million, a PE ratio of -7.96 and a beta of -0.47.

CAS Medical Systems (NASDAQ:CASM) last posted its quarterly earnings results on Thursday, August 2nd. The medical technology company reported ($0.08) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.07) by ($0.01). The firm had revenue of $5.29 million for the quarter, compared to the consensus estimate of $5.18 million. sell-side analysts predict that CAS Medical Systems will post -0.27 EPS for the current year.

CAS Medical Systems Company Profile

CAS Medical Systems, Inc, a medical technology company, develops, manufactures, and markets non-invasive patient monitoring products worldwide. The company provides FORE-SIGHT tissue oximeter monitors, sensors, and accessories, as well as offers FORE-SIGHT ELITE monitors. Its FORE-SIGHT absolute tissue oximeter provides non-invasive and quantitative measurement of oxygenation for cerebral tissue during surgery or critical care situations.

Further Reading: Why Dividend Stocks May Be Right for You

Insider Buying and Selling by Quarter for CAS Medical Systems (NASDAQ:CASM)

Receive News & Ratings for CAS Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CAS Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply